August 19: COVID-19 and the Immunosuppressed Immunocompromized Patient

$35.00

Date:
Thursday, August 19, 2021

Time:
0900 PT | 1000 MT/SK | 1100 CT | 1200 ET | 1300 AT

Duration:
120 minutes including a Q&A

Includes:
• A certificate of completion
• The live webinar event if registering prior to commencement
• The on-demand recording to watch at your convenience
• A handout in PDF format for viewing or self-printing

See below for the outline, speaker biography, and more.

Description

Date:
Thursday, August 19, 2021

Time:
0900 PT | 1000 MT/SK | 1100 CT | 1200 ET | 1300 AT

Duration:
120 minutes including a Q&A

Includes:
• A certificate of completion
• The live webinar event if registering prior to commencement
• The on-demand recording to watch at your convenience
• A handout in PDF format for viewing or self-printing

Objectives:
• Define the immunosuppressed/immunocompromised patient
• Understand how COVID-19 illness impacts immunosuppressed/immunocompromised patient populations
• Describe the different COVID-19 vaccines currently available
• Examine existing data to date that describes the immune response to vaccination for COVID-19 in immunosuppressed/immunocompromised patient populations
• Identify ways in which we can be effective advocates for our vulnerable patients

Description:
While many think that the risk of COVID-19 is largely over with vaccines, that is not the case with immunosuppressed and immunocompromised patients. Not only are there cases of newly immunocompromised patients appearing all the time, they are at once both more at risk to get COVID and to be sicker with COVID. Also, once they get the vaccine, they mount a less robust immune response to the virus. If you care for patients who are pregnant, who are undergoing cancer therapies and radiation, transplantation, dialysis, have HIV/AIDS or have serious underlying medical conditions such as autoimmune disorders, MS. diabetes, cardiovascular, liver or renal disease, this webinar will review the mechanisms of immunosupression, how and why these patients are at greater continuing risk, and review vaccines and the immune responses based on what we know from the existing data on these patients and then vaccines.

Who Should Attend?:
• Nurses in all settings that care for Immunosuppressed and Immunocomprimized Clients:
• HIV,Cancer, MS. Pregnancy, Transplantation,Cardiovascular, Diabetes, Geriatric, & Radiation
• Oncology Nurses; Transplantation, Perinatal, Geriatric, and COVID Nurses
• Primary Care, Home & Community Health Nurses; Tele-Health Nurses
• Nurse Practitioners, Infection Control, Outpost & Occupational Health Nurses
• Pharmacists, Dieticians, Educators, and Managers

Christina Kim, MSN, NP,  AGPCNP-BC

Christina Kim is a nurse practitioner at the Massachusetts General Hospital in Boston, Massachusetts, USA. She hold her bachelor’s degree in Biochemistry and has many years of experience working in a basic science laboratory setting. She currently works as an oncology nurse practitioner, specifically in medical oncology with sarcoma patients. She is a sub-investigator on several clinical trials. Christina is also a medical/science communicator on various social media platforms.